B220

B220 is an antiviral agent which can inhibit the growth of HSV-1, HSV-2 and human cytomegalovirus (CMV) .

Product Specifications

CAS Number

[112228-65-6]

UNSPSC

12352005

Hazard Statement

H302, H315, H319, H335

Target

CMV; HSV

Type

Reference compound

Related Pathways

Anti-infection

Applications

Cancer-programmed cell death

Field of Research

Cancer; Infection

Assay Protocol

https://www.medchemexpress.com/B220.html

Purity

99.0

Solubility

10 mM in DMSO

Smiles

CC1=C(C)C=C2N=C3C(N(CCN(C)C)C4=C3C=CC=C4)=NC2=C1

Molecular Formula

C20H22N4

Molecular Weight

318.42

Precautions

H302, H315, H319, H335

References & Citations

[1]Mohammed Homman, et al. Pharmaceutical formulation of B220 for topical treatment of herpes. EP 2489354 A1.|[2]Harbecke O, et al. The synthetic non-toxic drug 2,3-dimethyl-6 (2-dimethylaminoethyl) -6H-indolo- (2,3-b) quinoxaline inhibits neutrophil production of reactive oxygen species. J Leukoc Biol. 1999 Jun;65 (6) :771-7.